Related Experiment Video
Updated: Dec 26, 2025

08:22
Assessment and Characterization of Hyaloid Vessels in Mice
Published on: May 15, 2019
9.6K
Hip Morphology in Mucolipidosis Type II.
Luise Sophie Ammer1,2, Esmeralda Oussoren3, Nicole Maria Muschol1,2
1Department of Pediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Journal of Clinical Medicine
|March 19, 2020
Summary
Mucolipidosis type II (MLII) causes severe hip dysplasia. While acetabular dysplasia didn't significantly progress overall, specific radiographic signs like supra-acetabular constrictions were common in MLII patients.
Area of Science:
- Medical Imaging
- Genetics and Genetic Diseases
- Skeletal Dysplasias
Background:
- Mucolipidosis type II (MLII) is a rare lysosomal storage disorder.
- Defective lysosomal enzyme trafficking is the underlying cause of MLII.
- Severe skeletal abnormalities, particularly hip dysplasia, are characteristic of MLII.
Purpose of the Study:
- To characterize hip morphology in MLII patients.
- To investigate the natural progression of hip pathologies in MLII.
- To establish a baseline for evaluating future therapies.
Main Methods:
- Systematic evaluation of plain radiographs, ultrasounds, and MRI.
- Retrospective chart review of international, two-centered MLII patient data.
- Inclusion criteria: MLII diagnosis with at least one pelvic radiograph.
Main Results:
- Common radiographic findings included femoral cloaking, rickets/hyperparathyroidism-like changes, and supra-acetabular/femoral neck constrictions.
- Acetabular and migration indexes showed significant worsening in female patients.
- Overall, no substantial progression of acetabular dysplasia was observed across the study group.
Conclusions:
- Understanding MLII hip morphology is crucial for early diagnosis and management.
- This study provides insights into the natural history of hip disease in MLII.
- Findings can aid in assessing the skeletal impact of emerging MLII treatments.
Related Concept Videos
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Intralumenal Vesicles and Multivesicular Bodies
4.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
289
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
289

